Immunofluorescence and confocal microscopy for ex‐vivo diagnosis of melanocytic and non‐melanocytic skin tumors: A pilot study

Background Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of biophotonics Ročník 11; číslo 3
Hlavní autoři: Hartmann, Daniela, Krammer, Sebastian, Vural, Secil, Bachmann, Mario Raphael, Ruini, Cristel, Sárdy, Miklós, Ruzicka, Thomas, Berking, Carola, von Braunmühl, Tanja
Médium: Journal Article
Jazyk:angličtina
Vydáno: Weinheim WILEY‐VCH Verlag GmbH & Co. KGaA 01.03.2018
Wiley Subscription Services, Inc
Témata:
ISSN:1864-063X, 1864-0648, 1864-0648
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of the diagnosis performed by ex‐vivo CLSM. Methods The tissue probes from various skin tumors were stained with FITC‐labeled S‐100A10, Melan‐A and anti‐Ber‐EP4 antibodies before examination with ex‐vivo CLSM in the fluorescence and reflectance modes. Results were compared to negative controls and conventional histopathology. The staining protocols were evaluated by establishing a scoring system according to the signal intensity found in ex‐vivo CLSM. Results S100 immunostaining was successful in 55.6%. Dilution of 1:200 resulted in the best possible evaluation of the tumor. The best suitable protocol was protocol B (phosphate buffered saline [PBS], without blocking agent). Melan A immunostaining was positive in 66.7%, the best dilution was 1:500 and protocol B (PBS, without blocking agent) was the most suitable. Ber‐EP4 immunostaining presented a signal in 85.7%, the best dilutions were 1:200 and 1:500 and protocol A (PBS, with blocking agent) showed most optimal results. Conclusion The use of fluorescent‐labeled antibodies in ex‐vivo CLSM is possible and could improve intraoperative diagnostics of skin tumors. Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) enables intraoperative tissue diagnostics on a level equivalent to histopathology. Tissue probes from melanoma, melanocytic nevus, basal and squamous cell carcinoma were stained with FITC‐labeled S100, Melan A and Ber‐EP4 antibodies. S100 immunostaining was successful in 55.6%, Melan A in 66.7% and Ber‐EP4 in 85.7%. In combination with the application of fluorescent dyes, ex‐vivo CLSM offers unique possibilities of rapid tissue examination.
AbstractList BackgroundEx‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of the diagnosis performed by ex‐vivo CLSM.MethodsThe tissue probes from various skin tumors were stained with FITC‐labeled S‐100A10, Melan‐A and anti‐Ber‐EP4 antibodies before examination with ex‐vivo CLSM in the fluorescence and reflectance modes. Results were compared to negative controls and conventional histopathology. The staining protocols were evaluated by establishing a scoring system according to the signal intensity found in ex‐vivo CLSM.ResultsS100 immunostaining was successful in 55.6%. Dilution of 1:200 resulted in the best possible evaluation of the tumor. The best suitable protocol was protocol B (phosphate buffered saline [PBS], without blocking agent). Melan A immunostaining was positive in 66.7%, the best dilution was 1:500 and protocol B (PBS, without blocking agent) was the most suitable. Ber‐EP4 immunostaining presented a signal in 85.7%, the best dilutions were 1:200 and 1:500 and protocol A (PBS, with blocking agent) showed most optimal results.ConclusionThe use of fluorescent‐labeled antibodies in ex‐vivo CLSM is possible and could improve intraoperative diagnostics of skin tumors.
Ex-vivo confocal laser scanning microscopy (ex-vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of the diagnosis performed by ex-vivo CLSM.BACKGROUNDEx-vivo confocal laser scanning microscopy (ex-vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of the diagnosis performed by ex-vivo CLSM.The tissue probes from various skin tumors were stained with FITC-labeled S-100A10, Melan-A and anti-Ber-EP4 antibodies before examination with ex-vivo CLSM in the fluorescence and reflectance modes. Results were compared to negative controls and conventional histopathology. The staining protocols were evaluated by establishing a scoring system according to the signal intensity found in ex-vivo CLSM.METHODSThe tissue probes from various skin tumors were stained with FITC-labeled S-100A10, Melan-A and anti-Ber-EP4 antibodies before examination with ex-vivo CLSM in the fluorescence and reflectance modes. Results were compared to negative controls and conventional histopathology. The staining protocols were evaluated by establishing a scoring system according to the signal intensity found in ex-vivo CLSM.S100 immunostaining was successful in 55.6%. Dilution of 1:200 resulted in the best possible evaluation of the tumor. The best suitable protocol was protocol B (phosphate buffered saline [PBS], without blocking agent). Melan A immunostaining was positive in 66.7%, the best dilution was 1:500 and protocol B (PBS, without blocking agent) was the most suitable. Ber-EP4 immunostaining presented a signal in 85.7%, the best dilutions were 1:200 and 1:500 and protocol A (PBS, with blocking agent) showed most optimal results.RESULTSS100 immunostaining was successful in 55.6%. Dilution of 1:200 resulted in the best possible evaluation of the tumor. The best suitable protocol was protocol B (phosphate buffered saline [PBS], without blocking agent). Melan A immunostaining was positive in 66.7%, the best dilution was 1:500 and protocol B (PBS, without blocking agent) was the most suitable. Ber-EP4 immunostaining presented a signal in 85.7%, the best dilutions were 1:200 and 1:500 and protocol A (PBS, with blocking agent) showed most optimal results.The use of fluorescent-labeled antibodies in ex-vivo CLSM is possible and could improve intraoperative diagnostics of skin tumors.CONCLUSIONThe use of fluorescent-labeled antibodies in ex-vivo CLSM is possible and could improve intraoperative diagnostics of skin tumors.
Ex-vivo confocal laser scanning microscopy (ex-vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of the diagnosis performed by ex-vivo CLSM. The tissue probes from various skin tumors were stained with FITC-labeled S-100A10, Melan-A and anti-Ber-EP4 antibodies before examination with ex-vivo CLSM in the fluorescence and reflectance modes. Results were compared to negative controls and conventional histopathology. The staining protocols were evaluated by establishing a scoring system according to the signal intensity found in ex-vivo CLSM. S100 immunostaining was successful in 55.6%. Dilution of 1:200 resulted in the best possible evaluation of the tumor. The best suitable protocol was protocol B (phosphate buffered saline [PBS], without blocking agent). Melan A immunostaining was positive in 66.7%, the best dilution was 1:500 and protocol B (PBS, without blocking agent) was the most suitable. Ber-EP4 immunostaining presented a signal in 85.7%, the best dilutions were 1:200 and 1:500 and protocol A (PBS, with blocking agent) showed most optimal results. The use of fluorescent-labeled antibodies in ex-vivo CLSM is possible and could improve intraoperative diagnostics of skin tumors.
Background Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination immunohistochemistry enables to distinguish various cell types. The possibility of immunofluorescent techniques could enhance the accuracy of the diagnosis performed by ex‐vivo CLSM. Methods The tissue probes from various skin tumors were stained with FITC‐labeled S‐100A10, Melan‐A and anti‐Ber‐EP4 antibodies before examination with ex‐vivo CLSM in the fluorescence and reflectance modes. Results were compared to negative controls and conventional histopathology. The staining protocols were evaluated by establishing a scoring system according to the signal intensity found in ex‐vivo CLSM. Results S100 immunostaining was successful in 55.6%. Dilution of 1:200 resulted in the best possible evaluation of the tumor. The best suitable protocol was protocol B (phosphate buffered saline [PBS], without blocking agent). Melan A immunostaining was positive in 66.7%, the best dilution was 1:500 and protocol B (PBS, without blocking agent) was the most suitable. Ber‐EP4 immunostaining presented a signal in 85.7%, the best dilutions were 1:200 and 1:500 and protocol A (PBS, with blocking agent) showed most optimal results. Conclusion The use of fluorescent‐labeled antibodies in ex‐vivo CLSM is possible and could improve intraoperative diagnostics of skin tumors. Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) enables intraoperative tissue diagnostics on a level equivalent to histopathology. Tissue probes from melanoma, melanocytic nevus, basal and squamous cell carcinoma were stained with FITC‐labeled S100, Melan A and Ber‐EP4 antibodies. S100 immunostaining was successful in 55.6%, Melan A in 66.7% and Ber‐EP4 in 85.7%. In combination with the application of fluorescent dyes, ex‐vivo CLSM offers unique possibilities of rapid tissue examination.
Author Vural, Secil
Bachmann, Mario Raphael
Ruini, Cristel
Berking, Carola
von Braunmühl, Tanja
Ruzicka, Thomas
Hartmann, Daniela
Sárdy, Miklós
Krammer, Sebastian
Author_xml – sequence: 1
  givenname: Daniela
  orcidid: 0000-0002-1002-8133
  surname: Hartmann
  fullname: Hartmann, Daniela
  email: daniela.hartmann@med.uni-muenchen.de
  organization: University Hospital, LMU
– sequence: 2
  givenname: Sebastian
  surname: Krammer
  fullname: Krammer, Sebastian
  organization: University Hospital, LMU
– sequence: 3
  givenname: Secil
  surname: Vural
  fullname: Vural, Secil
  organization: University Hospital, LMU
– sequence: 4
  givenname: Mario Raphael
  surname: Bachmann
  fullname: Bachmann, Mario Raphael
  organization: University Hospital, LMU
– sequence: 5
  givenname: Cristel
  surname: Ruini
  fullname: Ruini, Cristel
  organization: University Hospital, LMU
– sequence: 6
  givenname: Miklós
  surname: Sárdy
  fullname: Sárdy, Miklós
  organization: Semmelweis University
– sequence: 7
  givenname: Thomas
  surname: Ruzicka
  fullname: Ruzicka, Thomas
  organization: University Hospital, LMU
– sequence: 8
  givenname: Carola
  surname: Berking
  fullname: Berking, Carola
  organization: University Hospital, LMU
– sequence: 9
  givenname: Tanja
  surname: von Braunmühl
  fullname: von Braunmühl, Tanja
  organization: University Hospital, LMU
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28949458$$D View this record in MEDLINE/PubMed
BookMark eNpdkc1OGzEUhS1E1ZC0W5bIEhs2Sf0zPzY7ikpJhcQGpO4sj-1BDjO-YTxDmV3FE_CMPEkdQqOqK9_r-_nq-Jwp2g8QHEKHlCwoIezLqvKwYISWqaF0Dx1QUWRzUmRif1fznxM0jXFFSEF4zj-iCRMyk1kuDtDzsm2HAHUzQOeiccE4rIPFBkINRje49aaDaGA94ho67J5ef788-kfA1uu7ANFHDDVuXaMDmLH35u15Upm4f2_jvQ-4H1ro4ik-w2vfQI9jP9jxE_pQ6ya6z-_nDN1efLs5v5xfXX9fnp9dzVdM5HTObUmFLKu8znTueC05ZZWVhnAhuHBC0ipjtCqtsHlRFaXMjeSVtq7QJRPC8hk62e5dd_AwuNir1qcfN0mjgyEqKjPOBBM0S-jxf-gKhi4kdSp5TXIhJeOJOnqnhqp1Vq073-puVH_dTYDcAr9848bdnBK1yU5tslO77NSPr8vrXcf_AE8hkpU
ContentType Journal Article
Copyright 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
2018 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml – notice: 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
– notice: 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
– notice: 2018 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
DBID NPM
7QO
7SP
7SR
7U5
8FD
FR3
JG9
K9.
L7M
P64
7X8
DOI 10.1002/jbio.201700211
DatabaseName PubMed
Biotechnology Research Abstracts
Electronics & Communications Abstracts
Engineered Materials Abstracts
Solid State and Superconductivity Abstracts
Technology Research Database
Engineering Research Database
Materials Research Database
ProQuest Health & Medical Complete (Alumni)
Advanced Technologies Database with Aerospace
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
Materials Research Database
Engineered Materials Abstracts
Biotechnology Research Abstracts
Technology Research Database
Electronics & Communications Abstracts
ProQuest Health & Medical Complete (Alumni)
Solid State and Superconductivity Abstracts
Engineering Research Database
Advanced Technologies Database with Aerospace
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Materials Research Database
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1864-0648
EndPage n/a
ExternalDocumentID 28949458
JBIO201700211
Genre article
Journal Article
GroupedDBID ---
05W
0R~
1OC
31~
33P
3SF
4.4
52U
52V
53G
5DZ
5GY
66C
8-0
8-1
A00
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCUV
ABJNI
ABLJU
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BNHUX
BOGZA
BRXPI
CS3
DCZOG
DR2
DRFUL
DRMAN
DRSTM
EBD
EBS
EJD
EMOBN
F5P
FEDTE
FUBAC
G-S
GODZA
HGLYW
HVGLF
HZ~
IX1
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
NNB
O9-
OIG
P2W
P4E
PQQKQ
ROL
SUPJJ
SV3
W99
WBKPD
WIH
WIJ
WIK
WOHZO
WXSBR
WYJ
XV2
ZZTAW
AGHNM
NPM
7QO
7SP
7SR
7U5
8FD
AAMMB
AEFGJ
AEYWJ
AGXDD
AGYGG
AIDQK
AIDYY
FR3
JG9
K9.
L7M
P64
7X8
ID FETCH-LOGICAL-j2851-3d71897b5f4a5e3f9312bd9c038838e891b421b7d8d56b6795c93bade6a7288d3
IEDL.DBID DRFUL
ISICitedReferencesCount 27
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000426731000027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1864-063X
1864-0648
IngestDate Sun Nov 09 08:57:07 EST 2025
Sat Nov 29 14:52:56 EST 2025
Thu Apr 03 07:02:52 EDT 2025
Wed Jan 22 16:48:47 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords diagnostics in dermatology
metastasis
fluorescence confocal microscopy
basal cell carcinoma
melanoma
skin surgery
skin tumors
immunofluorescence
Language English
License 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-j2851-3d71897b5f4a5e3f9312bd9c038838e891b421b7d8d56b6795c93bade6a7288d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1002-8133
PMID 28949458
PQID 2010589923
PQPubID 1006377
PageCount 8
ParticipantIDs proquest_miscellaneous_1943282814
proquest_journals_2010589923
pubmed_primary_28949458
wiley_primary_10_1002_jbio_201700211_JBIO201700211
PublicationCentury 2000
PublicationDate March 2018
PublicationDateYYYYMMDD 2018-03-01
PublicationDate_xml – month: 03
  year: 2018
  text: March 2018
PublicationDecade 2010
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
– name: Jena
PublicationTitle Journal of biophotonics
PublicationTitleAlternate J Biophotonics
PublicationYear 2018
Publisher WILEY‐VCH Verlag GmbH & Co. KGaA
Wiley Subscription Services, Inc
Publisher_xml – name: WILEY‐VCH Verlag GmbH & Co. KGaA
– name: Wiley Subscription Services, Inc
References 2007; 39
2009; 24
2012
2006; 54
2015; 73
2009; 160
2013; 149
2006; 17
2017; 45
2013; 227
2017; 23
2016; 168
2016; 31
1996; 93
2016; 143
2005
2014; 171
2008; 144
1998; 22
2016; 34
2015; 173
2015; 151
2007; 156
2009; 14
1990; 43
2015; 172
2004; 51
2015; 29
2017; 10
2015; 41
2015; 21
2005; 10
2009; 161
2016; 9
2011; 165
2016; 23
2016; 22
References_xml – volume: 54
  start-page: 638
  year: 2006
  publication-title: J. Am. Acad. Dermatol.
– volume: 151
  start-page: 1034
  year: 2015
  publication-title: JAMA Dermatol.
– volume: 41
  start-page: 1437
  year: 2015
  publication-title: Dermatol. Surg.
– volume: 9
  start-page: 376
  year: 2016
  publication-title: J. Biophotonics
– volume: 172
  start-page: 1037
  year: 2015
  publication-title: Br. J. Dermatol.
– volume: 23
  start-page: 159
  year: 2016
  publication-title: Adv. Anat. Pathol.
– volume: 168
  start-page: 207
  year: 2016
  publication-title: Am. J. Ophthalmol.
– year: 2005
– volume: 45
  start-page: 442
  year: 2017
  end-page: 447
  publication-title: Clin. Exp. Ophthalmol.
– volume: 10
  start-page: 128
  year: 2017
  publication-title: J. Biophotonics
– volume: 10
  year: 2005
  publication-title: J. Biomed. Opt.
– volume: 171
  start-page: 561
  year: 2014
  publication-title: Br. J. Dermatol.
– volume: 31
  start-page: 921
  year: 2016
  publication-title: Lasers Med. Sci.
– volume: 29
  start-page: 1135
  year: 2015
  publication-title: J. Eur. Acad. Dermatol. Venereol.
– volume: 14
  start-page: 34012
  year: 2009
  publication-title: J. Biomed. Opt.
– volume: 171
  start-page: 1044
  year: 2014
  publication-title: Br. J. Dermatol.
– volume: 143
  start-page: 564
  year: 2016
  publication-title: Ann. Dermatol. Venereol.
– volume: 161
  start-page: 1307
  year: 2009
  publication-title: Br. J. Dermatol.
– volume: 165
  start-page: 61
  year: 2011
  publication-title: Br. J. Dermatol.
– volume: 22
  start-page: 976
  year: 1998
  publication-title: Am. J. Surg. Pathol.
– volume: 93
  start-page: 5915
  year: 1996
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– year: 2012
– volume: 21
  start-page: 114
  year: 2015
  publication-title: Skin Res. Technol.
– volume: 227
  start-page: 89
  year: 2013
  publication-title: Dermatology
– volume: 156
  start-page: 1196
  year: 2007
  publication-title: Br. J. Dermatol.
– volume: 73
  start-page: 321
  year: 2015
  publication-title: J. Am. Acad. Dermatol.
– volume: 144
  start-page: 1597
  year: 2008
  publication-title: Arch. Dermatol.
– volume: 34
  start-page: 497
  year: 2016
  publication-title: Dermatol. Clin.
– volume: 149
  start-page: 839
  year: 2013
  publication-title: JAMA Dermatol.
– volume: 17
  start-page: 182
  year: 2006
  publication-title: Dermatitis
– volume: 22
  start-page: 203
  year: 2016
  publication-title: Skin Res. Technol.
– volume: 160
  start-page: 1242
  year: 2009
  publication-title: Br. J. Dermatol.
– volume: 39
  start-page: 696
  year: 2007
  publication-title: Lasers Surg. Med.
– volume: 173
  start-page: 128
  year: 2015
  publication-title: Br. J. Dermatol.
– volume: 43
  start-page: 213
  year: 1990
  publication-title: J. Clin. Pathol.
– volume: 23
  start-page: 121
  year: 2017
  publication-title: Skin Res. Technol.
– volume: 51
  start-page: 923
  year: 2004
  publication-title: J. Am. Acad. Dermatol.
– volume: 24
  start-page: 819
  year: 2009
  publication-title: Lasers Med. Sci.
– volume: 34
  start-page: 527
  year: 2016
  publication-title: Dermatol. Clin.
SSID ssj0060353
Score 2.2881587
Snippet Background Ex‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination...
Ex-vivo confocal laser scanning microscopy (ex-vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination...
BackgroundEx‐vivo confocal laser scanning microscopy (ex‐vivo CLSM) offers rapid examination of freshly excised tissue. During the conventional examination...
SourceID proquest
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
SubjectTerms Antibodies
basal cell carcinoma
Confocal microscopy
Diagnosis
diagnostics in dermatology
Dilution
Fluorescence
fluorescence confocal microscopy
Histopathology
Immunofluorescence
Immunohistochemistry
Lasers
melanoma
metastasis
Microscopy
Protocol
Reflectance
Scanning microscopy
Skin
Skin cancer
skin surgery
skin tumors
Tumors
Title Immunofluorescence and confocal microscopy for ex‐vivo diagnosis of melanocytic and non‐melanocytic skin tumors: A pilot study
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjbio.201700211
https://www.ncbi.nlm.nih.gov/pubmed/28949458
https://www.proquest.com/docview/2010589923
https://www.proquest.com/docview/1943282814
Volume 11
WOSCitedRecordID wos000426731000027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library
  customDbUrl:
  eissn: 1864-0648
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0060353
  issn: 1864-063X
  databaseCode: DRFUL
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELZgywEO5R-WlspIXKM2_je3UlhRhApCVNpbZMe2lHY3rja7q_ZW9Ql4Rp6EcbIbthInuCWeOLE0Hs838cxnhN4GwQnAepfZdIY7EyRkJmd5pgGcCmpyCIsO2sMm5MmJGo_1t40q_o4fov_hliyjXa-TgRvb7P8hDT2zVSreS_xyJBX3bhGYvHyAtj58H51-Wa_GAtraJHslWAbueLwmbjwg-7ff8DeIeRuxti5n9PD_B_sIba_gJj7s5sdjdMfXT9CDDRLCp-jmOJWIxDBZxFnL7VR6bGqHIVAOydHhacrZS9UrVxgQLvaXv65_LqtlxK5L06saHAOe-ompY3kFH2q717GG5zZbm_OqxvPFNM6ad_gQX1STOMctve0zdDr6-OPoU7Y6mSE7IwDRMurApWlpeWCGexo0zYl1ukzUMlR5pXPLSG6lU44LK6TmpabWOC-MJEo5-hwNYBj-JcLESEuc5sYIzkqildQyOGqkcjkjgQ7R7lotxcq8miJt4XOIFAmI3_RiMIy022FqHxdNkWtGUzyZsyF60amzuOgYPAqIMplmXA0RabXWCzoSZ1IkfRW9vorP74-_9nev_qXTDroP16rLXttFg_ls4V-je-VyXjWzPXRXjtXeaur-BhmP8Rk
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQiwQcypsuFDAS16jrt82tPFZdWBaEWmlvkR3bUspuXG12V_SG-AX8Rn4JdpINrcQJcUxsJ5ZmxvPN2PMZgJeeMxxhvc1MusOdcuwzjSjKVASnnGgUw6Jhc9mEmE7lbKY-d6cJUy1Myw_RJ9ySZTTrdTLwlJA-_MMaembKVL2XCOZwqu7dpVGXopLvvv0yOp1sl2M-JA0VJZKcZtEfz7bMjUN8ePULf8OYVyFr43NGt__DbO-AvQ5wwqNWQ-6Ca666B25doiG8D36MU5FI8PN1WDbsToWDurIwhso-uTq4SKf2Uv3KBYwYF7pvv77_3JSbAG17UK-sYfBw4ea6CsVF_FEzvApV7Hf5bf21rOBqvQjL-hU8guflPKxgQ3D7AJyO3p28Oc66uxmyMxxBWkZsdGpKGOapZo54RRA2VhWJXIZIJxUyFCMjrLSMGy4UKxQx2jquBZbSkodgJ07D7QOItTDYKqY1Z7TASgolvCVaSIso9mQADrZyyTsDq_O0ic9irIhj84u-OZpG2u_QlQvrOkeKkhRRIjoAj1p55ucth0ce40yqKJMDgBux9Q0tjTPOk7zyXl75-9fjT_3T438Z9BzcOD75OMkn4-mHJ-AmjuCoTeUcgJ3Vcu2eguvFZlXWy2edBv8G2Zf0HA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELZQFyE48L9QWMBIXKOt_21uC0tFYVVWiJV6i-zYlrK0cdW0FXtDPAHPyJNgJ2nYlTghjrHjxNJ4PN_YM98A8MpzhiOst5lJNdwpxz7TiKJMRXDKiUbRLRo1xSbEdCpnM3XaRROmXJiWH6I_cEua0ezXScHd0vrDP6yh56ZM2XuJYA6n7N49mirJDMDe8efx2cluO-Yj0lBRIslpFu3xbMfcOMKHV7_wN4x5FbI2Nmd85z_M9i643QFOeNSukHvgmqvug1uXaAgfgB-TlCQS_HwTVg27U-GgriyMrrJPpg4uUtReyl-5gBHjQvft1_ef23IboG0D9coaBg8Xbq6rUFzEHzXDq1DF9y631l_LCq43i7CqX8MjuCznYQ0bgtuH4Gz87svb91lXmyE7xxGkZcRGo6aEYZ5q5ohXBGFjVZHIZYh0UiFDMTLCSsu44UKxQhGjreNaYCkt2QeDOA33GECshcFWMa05owVWUijhLdFCWkSxJ0NwsJNL3ilYnadLfBZ9RRy7X_bdUTXSfYeuXNjUOVKUJI8S0SF41MozX7YcHnn0M6miTA4BbsTWd7Q0zjhP8sp7eeUf3kw-9U9P_mXQC3Dj9Hicn0ymH5-Cm7FZtqFsB2CwXm3cM3C92K7LevW8W8C_AXac85w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunofluorescence+and+confocal+microscopy+for+ex-vivo+diagnosis+of+melanocytic+and+non-melanocytic+skin+tumors%3A+A+pilot+study&rft.jtitle=Journal+of+biophotonics&rft.au=Hartmann%2C+Daniela&rft.au=Krammer%2C+Sebastian&rft.au=Vural%2C+Secil&rft.au=Bachmann%2C+Mario+Raphael&rft.date=2018-03-01&rft.issn=1864-0648&rft.eissn=1864-0648&rft.volume=11&rft.issue=3&rft_id=info:doi/10.1002%2Fjbio.201700211&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1864-063X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1864-063X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1864-063X&client=summon